156 related articles for article (PubMed ID: 12722921)
1. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies.
Katsuse O; Iseki E; Kosaka K
Neuropathology; 2003 Mar; 23(1):9-15. PubMed ID: 12722921
[TBL] [Abstract][Full Text] [Related]
2. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
3. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
[TBL] [Abstract][Full Text] [Related]
4. Frequency and distribution of TUNEL-positive neurons in brains of dementia with Lewy bodies: comparison with those in brains of Alzheimer's disease.
Katsuse O; Iseki E; Suzuki K; Kosaka K
Neuropathology; 2001 Dec; 21(4):272-7. PubMed ID: 11837533
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
7. Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology.
Armstrong RA; Cairns NJ
Neurol Sci; 2009 Dec; 30(6):471-7. PubMed ID: 19768369
[TBL] [Abstract][Full Text] [Related]
8. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
9. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies.
Gómez-Isla T; Growdon WB; McNamara M; Newell K; Gómez-Tortosa E; Hedley-Whyte ET; Hyman BT
Neurology; 1999 Dec; 53(9):2003-9. PubMed ID: 10599772
[TBL] [Abstract][Full Text] [Related]
11. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
14. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G
Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
Provias J; Jeynes B
Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
[TBL] [Abstract][Full Text] [Related]
18. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions.
Iseki E; Takayama N; Furukawa Y; Marui W; Nakai T; Miura S; Uéda K; Kosaka K
Neurosci Lett; 2002 Jul; 326(3):211-5. PubMed ID: 12095658
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
